Portfolio company
ViroVet
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops vaccines and antiviral drugs for livestock to control respiratory diseases and other viral infections in cattle, swine, sheep and goats.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Okapi Sciences
The company develops antiviral drugs for veterinary applications to treat viral infections in pets and livestock.
Resilient Biotics
This company develops microbiome-derived live biotherapeutics to prevent and treat respiratory diseases in livestock and humans.
Aptimmune
This company develops and manufactures mucosal vaccines for the global commercial swine industry to prevent viral respiratory diseases in livestock.
The Vaccine Group
The company develops recombinant viral-vector vaccines and biotherapeutics for livestock and companion animals to control infectious and chronic diseases.
ArkVax
ArkVax develops low-cost recombinant glycoconjugate vaccines for the livestock industry to protect animals from bacterial diseases and combat antimicrobial resistance.
Biotangents
The company develops rapid molecular diagnostic tests for infectious diseases in livestock to assist veterinarians and farmers with point-of-care animal health management.
Advanced Animal Diagnostics
This company develops on-farm diagnostic tests for livestock producers to detect infections and manage animal health.
Ruminant BioTech
This company develops a slow-release, methane-inhibiting bolus for cattle to reduce agricultural emissions for farmers and the livestock industry.
